Setting Realistic Treatment Goals for Localized Plaque Psoriasis

In the discussion, Dr. Tina Bhutani-Jacques reviews the management of a 34-year-old man with localized plaque psoriasis who is seeking effective long-term disease control while avoiding topical corticosteroids. She begins by outlining realistic treatment goals, explaining that for patients with limited body surface area involvement, the objective should be achieving clear or almost clear skin within three to six months. Dr. Bhutani-Jacques notes that treatment goals may be more conservative for patients with greater disease burden or involvement of difficult-to-treat areas, emphasizing the importance of individualizing expectations based on disease severity and patient characteristics.

The discussion then focuses on selecting the most appropriate topical therapy. Dr. Bhutani-Jacques explains that treatment decisions should extend beyond lesion location to include patient lifestyle, clothing preferences, visibility of affected areas, prior treatment experiences, and preferences regarding topical vehicles. By understanding these factors, clinicians can choose therapies that not only provide clinical benefit but also improve patient satisfaction and long-term adherence.

A major focus of the episode is counseling patients who are reluctant to use topical corticosteroids because of concerns about long-term adverse effects. Dr. Bhutani-Jacques describes "topical steroid fear" as a common issue encountered in clinical practice and emphasizes the importance of exploring the source of patients' concerns, correcting misinformation, and aligning treatment decisions with shared goals. She explains that while short-term corticosteroid therapy may still be appropriate for some patients with more extensive or highly inflamed disease, newer nonsteroidal topical therapies provide effective alternatives for many patients with localized plaque psoriasis. Throughout the discussion, Dr. Bhutani-Jacques underscores the value of shared decision-making, individualized treatment planning, and transitioning patients toward long-term nonsteroidal management whenever clinically appropriate.

In the next episode, "Addressing Steroid Fear with Non-Steroidal Treatment Options in Psoriasis," Dr. Bhutani-Jacques details the safety edge of newer non-steroidal topicals and a dosing strategy that can stretch out flare-free periods for patients like this one.